St Lukes Cancer Institute — Kansas City, Missouri

St Lukes Cancer Institute is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

St Lukes Cancer Institute has participated in 2 clinical trials.

Therapeutic areas: Breast Cancer, Advanced Solid Tumor, Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals, Orinove, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St Lukes Cancer Institute?

St Lukes Cancer Institute has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St Lukes Cancer Institute conducted?

St Lukes Cancer Institute has 2 clinical trials on record. Their work covers Breast Cancer, Advanced Solid Tumor, Metastatic Breast Cancer.

Is St Lukes Cancer Institute accredited by Crixeo Health?

St Lukes Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St Lukes Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.